Chronic Myeloid Leukaemia (CML)
CML is defined by the presence of the Philadelphia chromosome which can be detected by FISH in the peripheral blood or by molecular testing for the BCR-ABL fusion. Treatment has been revolutionised by the use of specific inhibitors of the ABL tyrosine kinase such as Imatinib.
